Onivyde IV infusion 43mg is manufactured by Nippon Servier (YJ code: 4240404A3027, standard: 43mg 10mL 1 bottle). This medicine, containing Irinotecan hydrochloride hydrate, is a liposomal topoisomerase inhibitor used in combination with other chemotherapy agents to treat metastatic pancreatic cancer, particularly after disease progression following other treatments.
Onivyde IV infusion 43mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →